NCT00492518View on ClinicalTrials.gov

Acetylcysteine, Theophylline, and a Combination of Both in the Prophylaxis of Contrast-Induced Nephropathy

PHASE4CompletedINTERVENTIONAL

Enrollment

254

Participants

Timeline

Start Date

February 28, 2002

Study Completion Date

October 31, 2004

Conditions

Contrast Induced NephropathyKidney DiseasesRenal FailureAdverse Effects

Interventions

DRUG

Acetylcysteine

DRUG

Theophylline

DRUG

Placebo

Trial Locations (1)

D-81675

Klinikum Rechts der Isar; Technical University of Munich, Munich

All Listed Sponsors

lead

Technical University of Munich

OTHER

NCT00492518 - Acetylcysteine, Theophylline, and a Combination of Both in the Prophylaxis of Contrast-Induced Nephropathy | Biotech Hunter | Biotech Hunter